- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03219541
Feasibility and Acceptability of a Text Messaging Intervention to Increase Smoking Cessation in Vietnam
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
For two-arm randomized control (RCT) pilot study (AIM 3), 100 current smokers will be observed to examine the preliminary effect of bidirectional SMS smoking cessation intervention. Subjects will be randomized into two groups (intervention vs. control), and compare the carbon monoxide (CO) validated 7-day point prevalence smoking abstinence rates at 4-week follow-up between intervention group (SMS smoking cessation treatment) and control group (assessment texts only).
Investigators will administer surveys at baseline, 4- and 12-weeks, and assess daily cigarette consumption using text message surveys. After the intervention, they will randomly select 10 participants from the intervention group to attend semi-structured interviews to obtain more in-depth understanding about the usefulness, usability, and acceptability of the intervention. Findings from the pilot RCT will be used to derive an estimate of the effect size, power, and sample size for a full-scale efficacy trial.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
New York
-
New York, New York, United States, 10016
- New York University School of Medicine
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- smoke ≥10 cigarettes per day
- capability to read and communicate
- plan to quit in the next 30 days
- has a mobile phone
- has experience using mobile phone text messaging during the past 6 months.
Exclusion Criteria:
- Under smoking cessation treatment or is participating in other tobacco cessation intervention
- pregnant or breastfeeding.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Interventional Automated mobile phone text
Subjects will receive 2 messages per day in the pre-quit phase, 3 messages per day on the quit date and the first week in the post-quit phase, and 2 messages per day in the last 3 weeks of the intervention.
During the intervention, participants will receive a text question at the end of every day asking you "How many cigarettes have you smoked today?"
|
Participants will receive 2 messages per day in the pre-quit phase, 3 messages per day on the quit date and the first week in the post-quit phase, and 2 messages per day in the last 3 weeks of the intervention.
|
Placebo Comparator: Control Texts
The intervention will consist of a 3-day pre-quit period and then a 4-week post-quit period.
Participants will receive 2 text questions each week asking the number of smoking days in the past week and the average number of cigarette smoked per day.
|
Participants will receive 2 text questions each week asking the number of smoking days in the past week and the average number of cigarette smoked per day.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Intervention Acceptability
Time Frame: 12 Weeks
|
Measured by ranking the mean score of each message
|
12 Weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of quit attempts
Time Frame: 12 Weeks
|
Measured using the 12-item Cigarette Dependence Scale (CDS)
|
12 Weeks
|
Percentage of respondents who have made at least one quit attempt during the intervention period,
Time Frame: 12 Weeks
|
Measured using the Smoking Absitinence Questionnaire (SAQ)
|
12 Weeks
|
Percent decrease in cigarette consumption per day at 2- and 4-week follow-ups compared to baseline
Time Frame: 4 Weeks
|
Measured using the Smoking Absitinence Questionnaire (SAQ)
|
4 Weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Donna Shelley, NYU Langone Health
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 17-00630
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Smoking
-
University of Southern CaliforniaAmerican Cancer Society, Inc.CompletedSmoking | Smoking Cessation | Smoking, Cigarette | Smoking Behaviors | Cessation, SmokingUnited States
-
University of VirginiaRecruitingSmoking | Smoking Cessation | Smoking Reduction | Smoking, Tobacco | Smoking, Cigarette | Quitting SmokingUnited States
-
Columbia UniversityNational Cancer Institute (NCI)RecruitingSmoking | Smoking Cessation | Smoking Reduction | Smoking BehaviorsUnited States
-
National Cancer Institute (NCI)CompletedSmoking | Smoking Cessation | Cigarette Smoking | Tobacco, SmokingUnited States
-
University GhentRecruitingSmoking | Smoking Tobacco | Smoking Prevention | Smoking CigaretteBelgium
-
Medical University of South CarolinaCompletedSmoking | Smoking Cessation | Smoking, Tobacco | Smoking, CigaretteUnited States
-
Maastricht University Medical CenterThe Investigative Desk; SEO Amsterdam Economics; IVO Research InstituteEnrolling by invitationSmoking Cessation | Smoking Reduction | Smoking, Tobacco | Smoking BehaviorsNetherlands
-
Jennifer Marler, MDCompletedSmoking Cessation | Smoking Reduction | Smoking, Tobacco | Smoking BehaviorsUnited States
-
Medical University of South CarolinaRecruitingSmoking | Smoking Cessation | Tobacco Smoking | Cigarette SmokingUnited States
-
Ghana Health ServicesKwame Nkrumah University of Science and TechnologyNot yet recruitingSmoking Cessation | Smoking Reduction | Smoking, Tobacco | Smoking Behaviors
Clinical Trials on Interventional Automated mobile phone text
-
University of California, DavisUniversity of California, San Francisco; Public Hospital Roatan, HondurasCompletedBreastfeeding | Breastfeeding, ExclusiveHonduras
-
Federal University of Minas GeraisUnknownCardiovascular DiseaseBrazil
-
The University of Hong KongHospital Authority, Hong KongUnknownDiabetes Mellitus, Type 2 | Appointments and SchedulesHong Kong
-
India Diabetes Research Foundation & Dr. A. Ramachandran...CompletedType 2 Diabetes MellitusIndia
-
University of StellenboschUniversity of British Columbia; McMaster UniversityCompletedText Messaging Plus Motivational Interviewing in Promotion of Breastfeeding Among HIV-infected WomenHIV Infections | Breast FeedingSouth Africa
-
Children's Hospital Los AngelesRecruitingMedication AdherenceUnited States
-
Qazvin University Of Medical SciencesUnknownCardiovascular Diseases | HypertensionIran, Islamic Republic of
-
Columbia UniversityNational Cancer Institute (NCI); Makerere UniversityNot yet recruiting
-
Yaounde Central HospitalCIHR Canadian HIV Trials NetworkCompleted
-
Abramson Cancer Center of the University of PennsylvaniaCompletedNon-small Cell Lung CancerUnited States